The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years. Vertex Pharmaceuticals, which makes the drug, has billed it as an effective ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.

Some you might hold only temporarily, while others you own for decades. David Jagielski (Eli Lilly): A forever stock you can ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...